This is not the most recent version of the article. View current version (9 OCT 2014)

Miscellaneous

You have free access to this content

Antibiotics for community acquired pneumonia in adult outpatients

  1. T Verheij Chairman*,
  2. M Kochen,
  3. IM Hoepelman,
  4. JW Lammers,
  5. J Macfarlane,
  6. M Woodhead

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 9 SEP 1999

DOI: 10.1002/14651858.CD002109


How to Cite

Verheij, T., Kochen, M., Hoepelman, I., Lammers, J., Macfarlane, J., Woodhead, M. 1999. Antibiotics for community acquired pneumonia in adult outpatients

Author Information

  1. University Medical Centre Utrecht, Department of General Practice, Utrecht, NETHERLANDS

*T Verheij, Chairman, Department of General Practice, University Medical Centre Utrecht, Universiteitsweg 100, Utrecht, 3584 CG, NETHERLANDS. t.j.m.verheij@med.uu.nl.

Publication History

  1. Published Online: 9 SEP 1999

SEARCH

This is not the most recent version of the article. View current version (09 OCT 2014)

Additional references

British Thoracic Soc

  • British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993;49:346-50.

ERS Task Force

  • ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 1998;11(4):986-91.

Fine

  • Fine MJ, Singer DE, Hanusa BH, Lave JR, Kapoor WN. Validation of a pneumonia prognostic index using the Medigroups comparative Hospital Database. Am J Med 1993;94:153-9.

Gilbert

  • Gilbert K, Gleason PP, Singer DE, et al. Variations in antimicrobial use and cost in more than 200 patients with community-acquired pneumonia. Am J Med 1998;104:17-27.

Heijden

  • van der Heijden GJ, van der Windt DA, de Winter AF. Physiotherapy for patients with soft tissue shoulder disorder: a systematic review of randomised clinical trials. BMJ 1997;315:25-30.

Jadad

  • Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality fo reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996;17:1-12.

Macfarlane

  • Macfarlane JT, Miller AC, Smith WHR, et al. Comparative radiographic features of community-acquired ledionnaires disease, pneumococcal pneumonia, mycoplasma pneumonia and psittacosis. Thorax 1984;39:28-33.

Minogue

  • Minogue MF, Coley CM, Fine MJ, Marrie TJ, Kapoor WN, Singer DE. Patients hospitalized after initial outpatient treatment for community-acquired pneumonia. Am Emerg Med 1998;31:376-80.

Niederman

  • Niederman MS, Bass JB, Campbell GC, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial therapy. Am Rev Respir Dis 1993;148:1418-26.

Schulz

  • Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomizing from reports of controlled trials published in obstetrics and gynaecology journals. JAMA 1994;272:125-8.

Torres

  • Torres A, Serra-Battles J, Ferrer A, et al. Severe community-acquired pneumonia: Epidemiology and prognostic factors. Am Rev Respir Dis 1991;144:312-8.

Tulder

  • Tulder MW van, Assendelft WJJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the cochrane collaboration back review group for spinal disorders. Spine 1997;22:2323-30.

Verhagen

  • Verhagen AP, Vet HCW de, Bie RA de, Kessels AGH, Boers M, Bouter LM, et al. The Delphi list: a criteria list for quality assessment of randomised clinical trials developed by Delphi consensus. Journal of Clinical Epidemiology in press.

Vet

  • Vet HCW de, Bie RA de, van Heijden GJMG der, Verhagen AP, Sijpkes P, Knipschild PG. Systematic reviews on the basis of methodological criteria. Physiotherapy 1997;83:284-9.

Windt

  • van Wintdt DA der, van Heijden GJ der, Scholten RJ, Koes BW, Bouter LM. The efficacy of non-steroidal anti inflammatory drugs (NSAIDS) for shoulder complaints. A systematic review. J Clin Epidemiol 1995;48:691-704.